OncoDaily Newsletter

Subscribe to our newsletter

Subscribe

Erika Hamilton: 10 New FDA-Approved Therapies for Breast Cancer Patients in 5 Months

Michael Fradley: Warsaw to Host the International Cardio-Oncology Society GCOS Meeting in 2028

Is Stage 4 DLBCL the Same as Stage 4 Solid Cancer? What It Means for Prognosis

How Do Our Genes Shape Our Lung Cancer Risk? - The Mark Foundation for Cancer Research

Jennifer S. Buell to Discuss Clinical Development in LATAM – MiNK Therapeutics

Oncology News, Insights, Stories by OncoDaily

FDA
Not To Miss

FDA Updates Regulations to Expand Alternatives to Animal Testing in Drug Development

Skin Cancer Foundation
Not To Miss

Skin Cancer Foundation and AgriSafe Urge Agricultural Workers to Prioritize Sun Protection

γδ T Cells
Lung Oncology

γδ T Cells Reveal an MHC-Independent Immune Vulnerability in Small Cell Lung Cancer

Fabrice André and Miguel Bronchud Discuss Key Challenges in Precision Cancer Prevention and Immuno-Oncology

Pashtoon Kasi: Can Treg Depletion Activate the Immune Response in MSS Colorectal Tumors?

Florian Lordick: How Should We Choose First-Line Treatment When CLDN18.2 and PD-L1 Coexist?

HER2CLIMB-05 Strengthens First-Line Maintenance in HER2-Positive Metastatic Breast Cancer With Tucatinib

Noha Rashad at COGC 2026: Precision Medicine in the Best and Worst of Times - Hope, but Not for All

Fabrice Barlesi: A Collective Mobilization to Advance Research Against Childhood Cancer

Erika Hamilton: 10 New FDA-Approved Therapies for Breast Cancer Patients in 5 Months

Voices

FDA Approvals

OncoDaily 100

Celebrities and Cancer

OncoCalendar

Immune-oncology

Gastrointestinal-Oncology

Breast-Oncology

Lung-Oncology

OncoDaily TV

Not To Miss

OncoGrants

Oncologist near me

Cancer types
CancerWorld

Oncologists

Oncology Drugs

OncoDaily Magazine

New Paper Alert

OncoDaily Medical Journal